Introduction
============

*Trichosporon* species are yeast-like fungi distributed widely in the environment; they commonly colonize the human skin and the respiratory or gastrointestinal tract but can cause lethal infections.[@b1-idr-11-1537]--[@b5-idr-11-1537] Trichosporonosis basically occurs in immunocompromised hosts, with the infection most commonly associated with broad-spectrum antibiotic therapy, chemotherapy, organ transplantation, surgical operation, as well as long-term intravascular device implantation, especially in the setting of hematological malignancy patients.[@b1-idr-11-1537]--[@b4-idr-11-1537],[@b6-idr-11-1537] Furthermore, due to delayed diagnosis and the lack of an optimal treatment strategy, mortality due to trichosporonosis remains high (50%--80%) in malignant hematological patients despite treatment with antifungal drugs.[@b7-idr-11-1537],[@b8-idr-11-1537]

The development of modern molecular identification methods has helped greatly in the classification of the genus *Trichosporon*, and to date, 16 species considered potential causative agents of human infections have been described, including *T. asahii*, *T. asteroides*, *T. cutaneum*, *T. inkin*, *T. japonicum*, *T. jirovecii*, *T. mucoides*, *T. dermatis*, *T. montevideense*, *T. coremiiforme*, *T. domesticum*, *T. faecale*, *T. loubieri*, *T. ovoides*, *T. dohaense*, and *T. mycotoxinivorans*.[@b4-idr-11-1537],[@b7-idr-11-1537],[@b9-idr-11-1537]--[@b11-idr-11-1537] Of these, *T. dohaense* was first described as causing superficial infections in immunocompromised patients in Qatar in 2009.[@b6-idr-11-1537]

Two cases of invasive infections caused by *T. dohaense* in two hospitals were identified under the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) program. Here, we describe these two case studies, including the clinical and molecular characteristics of the two *T. dohaense* isolates, as well as their notably reduced susceptibility to azoles, especially fluconazole.

Case review
-----------

### Patient 1

A 56-year-old male, presenting with non-Hodgkin's lymphoma with rectal or bladder involvement, was admitted to the intensive care unit (ICU) of Peking Union Medical College Hospital, Beijing, China, on 30 September 2010. The patient suffered from acute renal failure and acute myocardial infarction. He received chemotherapy and hemodialysis daily from Day 1 through to Day 8 of admission, as well as broad-spectrum antibiotics daily from Day 5 to Day 8, but he never had any exposure to antifungals during the hospitalization. He had a fever of up to 38.6°C on Day 5. A yeast isolate, identified as *T. asahii* by chromogenic agar (CHROMagar *Candida*; CHROMagar Company, Paris, France), was recovered on Day 11 from the blood culture taken on Day 7. The isolate was subsequently identified by rRNA gene sequencing as *T. dohaense* (see the following text). The patient was discharged against medical advice on Day 10 before the fungal isolate was identified and thus did not receive any antifungal therapy, although he was in a serious condition. The patient was subsequently lost to follow-up ([Table 1](#t1-idr-11-1537){ref-type="table"}).

### Patient 2

An 81-year-old female presented to the First Affiliated Hospital of Zhengzhou University on 10 March 2013 for treatment of rectovaginal fistula and incisional hernia after abdominal fistulation; she had continuous abdominal pain, nausea, and vomiting. She received broad-spectrum antibiotics from Day 0 through to Day 38 of admission. She was transferred to the ICU, where she was inserted with a right subclavian vein catheter and intrathoracic drain on Day 8 and received red blood cell transfusion. Blood (1,3)-β-[d]{.smallcaps}-glucan level was significantly raised on Day 25. The patient had a fever of up to 39.2°C on Day 29. Intravenous fluconazole was started (400 mg daily) on Day 28, then her temperature went down to about 38.0°C. On Day 37, the central venous catheter (CVC) was removed and sent for culture; meanwhile, central and peripheral blood cultures were also taken. An organism initially identified as *Candida albicans*/*C. tropicalis* was recovered from the catheter and blood culture in chromogenic agar, on Day 40. The patient was discharged in a serious condition against medical advice on Day 38 ([Table 1](#t1-idr-11-1537){ref-type="table"}).

Materials and methods
=====================

Identification of *T. dohaense* strains
---------------------------------------

The two isolates initially identified as *T. asahii* and *C. albicans/C. tropicalis* were isolated from the blood culture and the CVC culture of Patients 1 and 2, respectively ([Table 1](#t1-idr-11-1537){ref-type="table"}). The isolates were forwarded to a central laboratory (Department of Clinical Laboratory, Peking Union Medical College Hospital) for identification and further study, as previously described.[@b12-idr-11-1537] At the central laboratory, the two isolates were identified as follows: Patient 1, 10PU193 and Patient 2, 12ZZ130, based on the CHIF-NET system. The two isolates from Patient 2, which were initially identified as *C. albicans*/*C. tropicalis*, were confirmed as being of *T. dohaense* by rRNA sequencing at the central laboratory, and so was the isolate from Patient 1. The morphological characteristics of these unusual yeast isolates were determined by standard laboratory methods.[@b13-idr-11-1537] In addition, their appearance on chromogenic agar (CHRO-Magar *Candida*; CHROMagar Company) was examined and interpreted according to the manufacturer's instructions. To confirm the initial identification results from the referring laboratory, the VITEK 2 YST system was used at the central laboratory.

PCR and sequence-based identification
-------------------------------------

Genomic DNA was extracted by beating the suspension of isolates with glass beads, as described earlier.[@b14-idr-11-1537] All the isolates were subsequently identified as *T. dohaense* (see the following section).

Sequence-based identification
-----------------------------

For all the isolates, DNA extraction and amplification of the internal transcribed spacer (ITS) region, the D1/D2 domain of the 26S rRNA gene, and the intergenic spacer region-1 (IGS1) region were performed, respectively, with primer pairs ITS1/ITS4, F63/R635, and 26SF (IGS1-26SS)/5 SR (IGS12-58S), as previously described.[@b15-idr-11-1537],[@b16-idr-11-1537] The PCR products were sequenced in both directions using the DNA analyzer ABI 3730XL system (Applied Biosystems, Foster City, CA, USA). Species identification was performed by querying the obtained ITS, D1/D2, and IGS1 sequences against those in the GenBank database, with nucleotide Basic Local Alignment Search Tool (BLASTn, <http://blast.ncbi.nlm.nih.gov>).

Phylogenetic analysis
---------------------

The nucleotide sequences of ITS, D1/D2, and IGS1 regions for type strains of 16 *Trichosporon* human pathogen species available in GenBank as of 17 April 2018, and additional ITS and D1/D2 regions from literature review (19, 18, and 15 sequences for the ITS region, D1/D2 domain, and IGS1 region, respectively; [Figure 3](#f3-idr-11-1537){ref-type="fig"}) were downloaded. Phylogenetic analysis was performed with the software Molecular Evolutionary Genetic Analysis (MEGA software, version 6.0; <http://www.megasoftware.net>) using the neighbor-joining (NJ) method, with all positions containing gaps and missing data eliminated from the data set. The significance of the cluster nodes was determined by bootstrapping with 1,000 randomizations, and the NJ Tree was thereafter generated. The ITS, D1/D2, and IGS1 sequences of *Cryptococcus neoformans* (GenBank accession numbers EU240005, AF075484, and KC883800, respectively) were used as outgroups.

Identification and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS)
--------------------------------------------------------------------------------------------------------------------------

The identification of the two *T. dohaense* isolates was further explored using three MALDI-TOF MS systems -- the bioMérieux Vitek MS (bioMérieux, Marcy l'Etoile, France), Bruker Autoflex Speed (Bruker Daltonics, Bremen, Germany), and an automated mass spectrometry microbial identification system from Autobio Labtec Instruments Co, Ltd (Zhengzhou, China). Samples were prepared as previously described,[@b17-idr-11-1537] and identification of isolates was handled using In Vitro Diagnosis (IVD) Knowledgebase version 2.0 (software Myla, Vitek MS), Biotyper version 3.1 (Bruker Daltonics, Autoflex Speed), and Autof Acquirer version 1.0.26 (Autof MS1000, Autobio), respectively, following manufacturer's criteria for species and genus identification.

The protein profiles or mass spectra of the two isolates were further analyzed by constructing the main spectrum peaks (MSP) dendrogram using the correlation distance measure with the average linkage algorithm setting of the Bruker Biotyper software,[@b17-idr-11-1537] to determine whether their spectra exhibited any differences.

Antifungal susceptibility testing
---------------------------------

In vitro susceptibility testing of the two *T. dohaense* isolates to fluconazole, voriconazole, itraconazole, posaconazole, caspofungin, micafungin, amphotericin B, and 5-flucytosine was performed by the broth dilution methodology, according to the Clinical and Laboratory Standards Institute document M27-A3.[@b18-idr-11-1537] *C. parapsilosis*, American Type Culture Collection (ATCC) 22019, and *C. krusei*, ATCC 6258, were used as quality control strains. It is noteworthy that there are no established breakpoints for *Trichosporon* species to various antifungal agents, and so it is difficult to precisely confirm its susceptibility to the agents.[@b7-idr-11-1537],[@b19-idr-11-1537]

Literature review
-----------------

A PubMed search using the key words "*Trichosporon dohaense*" was performed, and the identified case studies were reviewed to identify additional information. All the identified papers were carefully read, paying special attention to demographic data, clinical specimens, risk factors, as well as the ITS, D1/D2, and IGS1 sequences of the species.

Nucleotide sequence accession numbers
-------------------------------------

The sequences of the ITS region, D1/D2 domain, and IGS1 region have been deposited in GenBank with accession numbers MG857685, MG857767, and MG871991, respectively, for strain 10PU193 (isolated from Patient 1) and accession numbers MG857710, MG857792, and MG872016, respectively, for 12ZZ130 (isolated from Patient 2). These sequences have been deposited as those of strains assigned as *T. dohaense*.

Ethics statement
----------------

Written informed consent to publish their case details was obtained from the patients or from the next of kin where the patient was unable to provide consent. The Human Research Ethics Committee of Peking Union Medical College Hospital provided permission to publish this report (PUMCHB-B-2-23-1).

Results
=======

Sequence-based identification
-----------------------------

The two *T. dohaense* isolates (10PU193 and 12ZZ130) had identical ITS region, D1/D2 domain, and IGS1 region sequences. By querying their sequences against those in the National Center for Biotechnology Information database, the ITS region and the D1/D2 domain sequences of the two *T. dohaense* strains showed 100% (405/405 bp) and 100% (517/517 bp) similarity to the ITS and D1/D2 sequences of *T. dohaense* type strain CBS10761^T^ (GenBank accession number FJ228471 and FJ228475), respectively ([Tables 2](#t2-idr-11-1537){ref-type="table"} and [3](#t3-idr-11-1537){ref-type="table"}). Species identification was not achieved by using the IGS1 region, as there is no *T. dohaense* reference IGS1 sequence in the GenBank. However, the IGS1 region can clearly distinguish the two isolates from other *Trichosporon* species (best hit identity ≤86%).

Phenotypic characteristics of *T. dohaense*
-------------------------------------------

The two *T. dohaense* isolates grew well at 28°C and 35°C, but failed to grow at 42°C, on Sabouraud dextrose agar. The colonies of both isolates were creamy, butyrous, white colored, and slow growing (\>48 hours to become a colony of \~1 mm in diameter on the third zone) on Sabouraud dextrose agar ([Figure 1A--D](#f1-idr-11-1537){ref-type="fig"}). Microscopic examination showed budding yeast cells, hyphae, and arthroconidia ([Figure 1G and H](#f1-idr-11-1537){ref-type="fig"}). On CHROMagar *Candida*, *T. dohaense* cells were dark blue, similar to the color of *C. tropicalis*, but the moist colony characteristic was quite different from that of *T. asahii* ([Figure 1E and F](#f1-idr-11-1537){ref-type="fig"}). In the central laboratory, repeat testing by biochemical identification systems also misidentified the two isolates (10PU193 and 12ZZ130) as *T. asahii* and *T. inkin*, respectively, by the VITEK 2 YST (identification rates 85% and 95%, respectively) system ([Table 2](#t2-idr-11-1537){ref-type="table"}).

Phylogenetic analysis
---------------------

To investigate the genetic relatedness of the two *T. dohaense* strains, the ITS, D1/D2, and IGS1 sequences of *T. dohaense* isolated from this study and those of 16 *Trichosporon* species with clinical relevance available in GenBank were subjected to phylogenetic analysis ([Figure 3](#f3-idr-11-1537){ref-type="fig"}). By NJ analysis, all the ITS, D1/D2, and IGS1 sequence alignments clustered the two *T. dohaense* isolates with *T. dohaense* type strain CBS10761^T^, thus clearly distinguishing them from other *Trichosporon* species recovered from humans ([Figure 3](#f3-idr-11-1537){ref-type="fig"}). Based on the ITS, D1/D2, and IGS1 sequences, the 16 *Trichosporon* species with clinical relevance identified in the literature clustered in three clades, including Ovoides, Gracile/Brassicae, and Cutaneum. Moreover, *T. dohaense* belongs to the Ovoides clade ([Figure 3](#f3-idr-11-1537){ref-type="fig"}). In addition, the IGS1 region showed the highest variation among the three regions, and the *T. dohaense* cluster corresponded to a unique species, with the IGS1 region of *T. dohaense* (824 bp) being much longer than that of other species (195--704 bp).

MALDI-TOF MS analysis
---------------------

The MS spectra of *T. dohaense* were not covered in the Vitek MS database but were available in the Bruker Biotyper and Autobio MS identification databases. Hence, the Vitek MS system misidentified the two isolates as *T. ovoides*/*T. asteroids* and *T. ovoides*, with confidence values of 50/50 and 99.9, respectively, whereas Bruker Biotyper and Autobio MS correctly identified the isolates ([Table 2](#t2-idr-11-1537){ref-type="table"}). In addition, the Bruker Biotyper system MSP dendrogram revealed that the spectra of the two isolates were identical ([Figure 2](#f2-idr-11-1537){ref-type="fig"}). At a distance-level cutoff of 900, 19 *Trichosporon* species were divided into three clusters, which had basic consistency with the taxon of the clades on analysis by rRNA gene tools, except for *T. montevideense* and *T. mycotoxinivorans*. Our two isolates clustered with the *T. dohaense* isolates in the database and were clearly distinct from other species, as shown by the MSP dendrogram.

Antifungal susceptibilities
---------------------------

[Table 2](#t2-idr-11-1537){ref-type="table"} shows that both *T. dohaense* isolates in the present study needed high minimal inhibitory concentrations (MICs) of caspofungin and micafungin, which was considered to be natural resistance to these agents (MIC \>8 µg/mL).[@b20-idr-11-1537] The two isolates had intermediate susceptibility to itraconazole (MIC 0.5 µg/mL), voriconazole (MIC 0.25 and 1 µg/mL), posaconazole (MIC 0.25 and 0.5 µg/mL), and fluconazole (MIC 8 and 16 µg/mL). The MICs for 5-flucytosine and amphotericin B were 4 and 1 µg/mL, respectively.

Literature review
-----------------

Only two relevant articles on *T. dohaense* were identified through PubMed literature search, with the reported strains all isolated from superficial infections. Three *T. dohaense* cases, including one case each of tinea pedis, onychomycosis, and superficial catheter site, were first described in Doha, Qatar, by Taj-Aldeen et al.[@b6-idr-11-1537] After this original description, the second case of *T. dohaense* was reported from a case of onychomycosis in 2016 in Assiut, Egypt.[@b21-idr-11-1537] We concluded that, in the first of the two articles identified in the literature, an immunocompromised state was the risk factor for infection by *T. dohaense*. Both the ITS and the D1/D2 sequences of *T. dohaense* strains in the previous studies clustered with those of the two isolates in our study, but only the ITS sequence was mentioned by the second report. The MSP dendrogram generated from the protein mass spectra of *T. dohaense* isolates from the first report also clustered with our two isolates ([Table 3](#t3-idr-11-1537){ref-type="table"}, [Figures 2](#f2-idr-11-1537){ref-type="fig"} and [3](#f3-idr-11-1537){ref-type="fig"}).[@b6-idr-11-1537],[@b21-idr-11-1537] Unfortunately, there was no IGS1 sequence available from literature review for investigation of the regional divergence of the species.

Discussion
==========

*T. dohaense* strains are rarely identified in the clinical microbiology laboratory, and the pathogenic role of this species remains uncertain. To the best of our knowledge, this is the first report on invasive infections caused by this rare *Trichosporon* species.

By detailed retrospective review of the medical chart records, we discovered that both the patients presenting with *T. dohaense* invasive infection suffered from tumor and underlying diseases. Cancer, vascular and urinary catheters, organ transplantation, and broad-spectrum antibiotic therapy are considered the main risk factors for invasive trichosporonosis. Both patients were in an immunocompromised state and had classical risk factors for invasive trichosporonosis;[@b7-idr-11-1537],[@b22-idr-11-1537] both were on broad-spectrum antibiotic therapy and ICU hospitalization. Patient 1 had undergone chemotherapy and hemodialysis, and Patient 2 had undergone major surgery within 30 days, had central venous catheters in situ, and was receiving parenteral nutrition. The risk factors for *T. dohaense* invasive infections are similar to those for other *Trichosporon* species.[@b8-idr-11-1537],[@b23-idr-11-1537]

Both patients were in a serious condition but got discharged against medical advice and were subsequently lost to follow-up. Although failure to follow up the patient to document prognosis and response to antifungal therapy is a limitation of our study, the course of infection in the two patients during hospitalization suggests a genuine infection rather than contamination or colonization with *T. dohaense*. Both patients were immunocompromised as they were cancer sufferers who accepted chemotherapy and thus were more susceptible to fungal infection. *T. dohaense* was recovered from the culture of blood from Patient 1. Furthermore, the patient had fever, leukocytosis, and elevated C-reactive protein, which is consistent with a fungal bloodstream infection.[@b24-idr-11-1537] The two isolates recovered from the blood culture from Patient 1 and the CVC culture from Patient 2 were both identified as *T. dohaense* and met the standard guidelines of catheter-associated bloodstream infections.[@b25-idr-11-1537] Patient 2 had a continuous fever for 10 days and the temperature decreased from 39.2°C to 38°C after fluconazole therapy. An abundant cell wall polysaccharide, (1,3)-β-[d]{.smallcaps}-glucan, is found in most fungi and is important in the diagnosis of invasive fungal infections. Patient 2 had a significantly raised level of this polysaccharide in the blood. Both patients had negative bacterial cultures and showed no response to antibiotic treatment. Based on the evidence outlined herein, it appears highly likely that the two *T. dohaense* strains isolated from the two patients were pathogens.

Misidentification of the *T. dohaense* isolates (10PU193 and 12ZZ130) was noted during our study, with the species easily confused with *C. tropicalis* and *C. albicans* on CHROM agar, respectively. Furthermore, a commonly used phenotypic identification system VITEK 2 YST may misidentify the species as two commonly encountered *Trichosporon* species, *T. asahii* and *T. inkin*. Accurate identification of *T. dohaense* is important to avoid administration of inappropriate antifungal therapy. DNA-based methods have been extensively used for the accurate identification of *Trichosporon* spp. Although the ITS region and the D1/D2 domain sequences were able to correctly assign the two *T. dohaense* isolates to species level, the IGS1 region is considered more suitable for accurate species identification of *Trichosporon* due to the higher discriminatory power.[@b26-idr-11-1537] Of note, there is no IGS1 region sequence available in the GenBank database, and our data provide the basis for future research.

The recent development of MALDI-TOF MS has provided a promising alternative for routine identification of *Trichosporon* species.[@b27-idr-11-1537],[@b28-idr-11-1537] The mass spectral data of *T. dohaense* were not represented in Vitek MS but in Bruker Biotyper and Autobio MS databases. Bruker Biotyper and Automated MS have the capacity to accurately identify *T. dohaense*, whereas the Vitek MS systems does not.

To this end, the mass spectra of the two *T. dohaense* strains in our study and the 19 *Trichosporon* species described in other studies were archived into the customer-specific sublibrary of the Biotyper software, following the manufacturer's protocol. Our analysis of the MSP dendrogram generated by the Bruker Biotype system showed that the spectra of the two clinical isolates described in this study clustered with the spectra of *T. dohaense* provided by the system. Furthermore, the protein heterogeneity clearly separated the *T. dohaense* isolates from other species, which was in accordance with the rRNA-discriminated clades, except for two species. Phylogenetic analysis demonstrated that the 16 *Trichosporon* species were clustered by rRNA sequences to Ovoides, Gracile/Brassicae, and Cutaneum clades, with *T. dohaense* confined to the Ovoides clade, which is consistent with results from previous studies.[@b7-idr-11-1537],[@b10-idr-11-1537] Although the ITS, D1/D2, and IGS1 regions can all clearly discriminate *T. dohaense* from other *Trichosporon* species, a comparative analysis of the phylogenetic tree constructed in our study suggested that the IGS1 region has the highest variation among the three regions.

*Trichosporon* has been reported to be the most common cause of noncandidal yeast infections in patients with hematological malignancies, and the infections are related to high mortality rates.[@b29-idr-11-1537] Since different *Trichosporon* species may exhibit different antifungal susceptibilities,[@b7-idr-11-1537] accurate identification is important to avoid inappropriate antifungal treatment. In our study, micafungin and caspofungin demonstrated no in vitro activity against *T. dohaense* as with other *Trichosporon* species.[@b3-idr-11-1537],[@b4-idr-11-1537] *T. dohaense* demonstrated the highest susceptibility to amphotericin B, with MIC of 1 µg/mL, which is in agreement with the findings of Taj-Aldeen et al.[@b6-idr-11-1537] We also noted that the MICs of the four azoles, especially fluconazole (8 and 16 µg/mL), for our two isolates are apparently higher than those from a previous study (1--4 µg/mL).[@b6-idr-11-1537] Furthermore, the MICs of the four azoles in our study were also higher than the MIC~50~ value of 43 isolates of *Trichosporon* species isolated from Taiwan during an 8-year study period with MICs of 4 µg/mL for fluconazole, 0.03 µg/mL for voriconazole, 0.12 µg/mL each for itraconazole and posaconazole, and 0.5 µg/mL for amphotericin B.[@b22-idr-11-1537] And the MICs of fluconazole and voriconazole for our study isolates was also higher than the MIC geomean of 62 *T. asahii* isolates for the CHIF-NET program (fluconazole 4 µg/mL, voriconazole 0.064 µg/mL). However, the current clinical data were insufficient to predict the correlation between in vitro susceptibility and in vivo response to therapy since the patients had not received antifungal therapy after culture.

Conclusion
==========

This study points to a possible emergence of *T. dohaense* as a significant opportunistic human invasive pathogen. The high MICs to all echinocandins and reduced susceptibility to azoles highlight the importance of accurate identification for appropriate therapy. Molecular methods are needed for accurate identification and further molecular characterization of this fungal species, in addition to conventional laboratory tests.
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![Phenotypic characteristics of two *Trichosporon dohaense* isolates.\
**Notes:** The isolates were grown on Sabouraud dextrose agar (**A--D**), chromogenic media CHROMagar *Candida* (**E**, **F**) and budding yeast cells, hyphae, and arthroconidia on Sabouraud dextrose agar by periodic acid methenamine silver staining and Gram's staining, respectively (**G**, **H**): Incubation conditions: **A**, **B**, and **E** -- 37°C, 48 hours; **C**, **D**, and **F**--**H** -- 37°C, 72 hours; **A** and **C**, *T. dohaense* 10PU193; **B** and **D**, *T. dohaense* 12ZZ130. In **E** and **F**, (a) indicates *T. dohaense* 10PU193; (b) *T. dohaense* 12ZZ130; (c) *T. asahii* CBS 2479; (d) *C. tropicalis* 10H1048; (e) *C. albicans* ATCC 90028; and (f) *C. krusei* ATCC 6258. The (d) isolate in panels **E** and **F** was selected from the CHIF-NET study.[@b12-idr-11-1537]\
**Abbreviation:** CHIF-NET, China Hospital Invasive Fungal Surveillance Net.](idr-11-1537Fig1){#f1-idr-11-1537}

![The MSP dendrogram generated from the protein mass spectra of the two *Trichosporon dohaense* isolates studied by Bruker Biotyper (Bremen, Germany), version 3.1.\
**Abbreviation:** MSP, main spectrum peaks.](idr-11-1537Fig2){#f2-idr-11-1537}

![The NJ tree of *Trichosporon dohaense* generated from *T. dohaense* ITS, D1/D2, and IGS1sequences from this study and the 16 *Trichosporon* species with clinical relevance available in GenBank, with *Cryptococcus neoformans* (GenBank accession number EU240005, AF075484, and KC883800, respectively) used as the outgroup.\
**Abbreviations:** IGS, intergenic spacer region; ITS, internal transcribed spacer; NJ, neighbor-joining.](idr-11-1537Fig3){#f3-idr-11-1537}

###### 

Clinical features of two patients with invasive infection caused by *Trichosporon dohaense*

  Clinical feature                                                                     Patient 1                                          Patient 2
  ------------------------------------------------------------------------------------ -------------------------------------------------- ------------------------------------------------
  Isolate ID number                                                                    10PU193                                            12ZZ130
                                                                                                                                          
  Age                                                                                  56                                                 81
  Gender                                                                               Male                                               Female
  Reason for hospital admission                                                        Non-Hodgkin's lymphoma                             Colorectal cancer
  Underlying disease                                                                   Acute renal failure, acute myocardial infarction   Hypertension, coronary heart disease, diabetes
  First isolation of *T. dohaense* (date[a](#tfn1-idr-11-1537){ref-type="table-fn"})   6/10/2010 (7)                                      17/04/2013 (37)
  Clinical status at time of positive culture                                                                                             
   Immunosuppressive state                                                             Yes                                                Yes
   Neutropenia (\<10^9^/L)                                                             No                                                 No
   Presence of CVC                                                                     No                                                 Yes
   Broad-spectrum antibiotics                                                          Yes                                                Yes
   Parenteral nutrition                                                                No                                                 Yes
   Surgery within 30 days                                                              No                                                 Yes
   Intensive care                                                                      Yes                                                Yes
   Previous antifungal agents within 30 days                                           No                                                 Yes
   Indwelling urinary catheter                                                         Yes                                                No
  Therapy                                                                                                                                 
   CVC removal (date[a](#tfn1-idr-11-1537){ref-type="table-fn"})                       Not applicable                                     Yes (37)
   Antifungal therapy after culture                                                    No                                                 No
   Outcome of patient                                                                  Discharge without medical advice                   Discharge without medical advice

**Note:**

Numbers in parentheses indicate the days from the beginning of hospitalization.

**Abbreviation:** CVC, central venous catheter.

###### 

Results of identification and antifungal susceptibility testing for *Trichosporon dohaense* isolates from this study

  Patient                                                                                                1                                        2
  ------------------------------------------------------------------------------------------------------ ---------------------------------------- -----------------------
  Isolate                                                                                                10PU193                                  12ZZ130
  Identification by DNA sequencing                                                                                                                
   ITS                                                                                                   *T. dohaense*                            *T. dohaense*
   D1/D2                                                                                                 *T. dohaense*                            *T. dohaense*
   IGS1                                                                                                  No identification                        No identification
  Identification by MALDI-TOF MS (scores/confidence values[a](#tfn3-idr-11-1537){ref-type="table-fn"})                                            
   Bruker Biotyper                                                                                       *T. dohaense* (2.193)                    *T. dohaense* (2.196)
   Vitek MS                                                                                              *T. ovoides* (50)*/T. asteroides* (50)   *T. ovoides* (99.9)
   Autobio MS                                                                                            *T. dohaense* (9.506)                    *T. dohaense* (9.562)
   VITEK 2 YST (rate)                                                                                    *T. asahii* (85%)                        *T. inkin* (95%)
  Antifungal susceptibility by broth microdilution (μg/m L)                                                                                       
   Caspofungin                                                                                           \>8                                      \>8
   Micafungin                                                                                            \>8                                      \>8
   Fluconazole                                                                                           8                                        16
   Voriconazole                                                                                          0.25                                     1
   Posaconazole                                                                                          0.25                                     0.5
   Itraconazole                                                                                          0.5                                      0.5
   Amphotericin B                                                                                        1                                        1
   5-Flucytosine                                                                                         4                                        4

**Notes:**

Scores for Bruker Biotyper, Vitek MS, and Autobio MS vary within the ranges of 0--3, 0--100, and 0--10, with zero indicating no relationship and the maximum indicating identical spectrum profiles.

**Abbreviations:** ITS, internal transcribed spacer; MALDI-TOF-MS, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry; IGS-1, intergenic spacer region-1.

###### 

Summary of *Trichosporon dohaense* isolates from published literatures

  Strain       Country   Reference                             Clinical specimen       Clinical finding          Patient age/gender   Patient origin   ITS        D1/D2       IGS                               
  ------------ --------- ------------------------------------- ----------------------- ------------------------- -------------------- ---------------- ---------- ----------- ---------- ----------- ---------- ----
  Case 14      Qatar     Taj-Aldeen et al[@b6-idr-11-1537]     Toenail                 Onychomycosis             70/F                 Qatar            FJ228476   Reference   FJ228473   Reference   --         --
  Case 17      Qatar     Taj-Aldeen et al[@b6-idr-11-1537]     Catheter                Catheter site infection   41/M                 Bangladesh       FJ228474   405/405     FJ228472   517/517     --         --
  Case 20      Qatar     Taj-Aldeen et al[@b6-idr-11-1537]     Skin scraping           Tinea pedis               34/M                 India            FJ228475   405/405     FJ228471   517/517     --         --
  AUMC 10212   Egypt     Abdel-Sater et al[@b21-idr-11-1537]   Fingernail              Onychomycosis             40/F                 Egypt            KU200438   548/405     --         --          --         --
  10PU193      China     This study                            Blood                   Fungemia                  55/M                 China            MG857685   504/405     MG857767   599/517     MG871991   --
  12ZZ130      China     This study                            Central vein catheter   Invasive infection        81/F                 China            MG857710   504/405     MG857792   599/517     MG872016   --

**Notes:**

Identity of the ITS, D1/D2 and IGS region sequences between type strain CBS 10761T and *T. dohaense*. "--" indicates data not available.

**Abbreviations:** ITS, internal transcribed spacer; IGS, intergenic spacer region-1; M, male; F, female.
